相关实验视频

Updated: Jun 12, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

异构干细胞移植后免疫复原的模式:来自资源有限国家的数据

Uzma Rahim¹, Raheel Iftikhar², Tariq Ghafoor³

¹Clinical Hematology, Armed Forces Institute of Bone Marrow Transplant Centre, Rawalpindi, PAK.

|September 23, 2024

概括

这项研究评估了异构干细胞移植 (Allo-HSCT) 后六个月的免疫复原 (IR). 除了CD4计数和CD4:CD8比率之外,观察到足够的IR,这表明在这个阶段免疫是可行的.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
移植科学移植科学

背景情况:

全源性造血干细胞移植 (Allo-HSCT) 是各种血液性恶性瘤和其他疾病的关键治疗方法.
在Allo-HSCT后的免疫复制 (IR) 对患者的康复和长期结果至关重要.
了解IR的模式对于优化移植后护理和治疗策略至关重要.

研究的目的:

为了确定六个月后异构干细胞移植后免疫复合 (IR) 的模式.
在接受Allo-HSCT的患者中评估先天性和适应性免疫恢复.
识别与免疫复合模式相关的因素.

主要方法:

一项前性观察性研究在巴基斯坦武装部队骨髓移植中心 (AFMBTC) 进行.
纳入标准包括所有接受Allo-HSCT的患者,不包括哈普罗相同或自身移植.
免疫复合被评估使用完整血细胞计数 (CBC) 对于先天性免疫 (中性粒细胞移植) 和淋巴细胞子集分析以及血清免疫球蛋白水平适应性免疫在移植后六个月.

主要成果:

该研究包括43名患者 (67%是男性),HSCT时平均年龄为11.19岁.
在移植前调节方案和CD4计数 (PChi=0.001) 之间发现了显著的关联.
还注意到GVHD预防和CD4计数 (PChi=0.04),干细胞来源和CD19水平 (PChi=0.008),患者-捐赠者性别差异和CD19水平 (PChi=0.05),以及患者-捐赠者与IgA,IgG和IgM水平之间的关系 (PChi=0.007,PChi=0.001,PChi=0.001分别).

结论:

在Allo-HSCT后六个月的免疫复制通常是充足的,有显著的例外是CD4计数和CD4:CD8比率.
这些发现表明,在Allo-HSCT接受者中,移植后的六个月可能是启动免疫程序的合适时间.
进一步的研究可以探索这些IR模式对患者免疫力和临床结果的长期影响.

关键词:

一个全源的产物.血液造血干细胞移植的结果是什么?免疫复合复合免疫复合这种白血病是白血病.巴基斯坦的巴基斯坦.

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...